Detalhe da pesquisa
1.
A qualitative study to understand the experience of somatostatin analog treatments from the perspective of patients with neuroendocrine tumors.
Support Care Cancer;
30(7): 6307-6316, 2022 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35476113
2.
Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Int J Cancer;
146(5): 1316-1323, 2020 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31509608
3.
PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly.
Adv Ther;
40(2): 671-690, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36502449
4.
Patients' satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors.
J Patient Rep Outcomes;
5(1): 82, 2021 Sep 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34491454
5.
Patient Survey of the Physical, Emotional, and Informational Challenges for Patients Living with Neuroendocrine Tumors.
Oncol Ther;
8(1): 67-80, 2020 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32700067
6.
Correction to: PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly.
Adv Ther;
41(6): 2531-2533, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38480663
7.
Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors: Results From a Large Patient Survey in the United States.
Pancreas;
46(5): 639-647, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28328615
8.
Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs.
J Glob Oncol;
3(1): 43-53, 2017 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28717741